Skip to main content
. 2012 Jan 2;22(4):1664–1669. doi: 10.1016/j.bmcl.2011.12.115

Table 2.

Anti-HBV activity and cytotoxicity of Compound 1 in vitro at day 9 of treatment

Compound (μmol/L) Cytotoxicity HBV DNA
HBeAg
HBsAg
CC50a IC50b SI IC50b SI IC50b SI
Compound 1 1747 3.72 469.0 75 23.0 80.00 21.0
ADV 1995 30.09 66.3 296 6.7 266.00 7.5

Selectivity index was determined as the CC50/IC50 value.

a

The cytotoxicity concentration of Compound 1 or ADV that reduced cell viability to 50% (CC50).

b

The concentrations of Compound 1 or ADV needed to inhibit.